Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors
CA 2243245 A1 · Owner: Board Of Regents, The University Of Texas System · Inventors: Garfield, Robert E.; Chwalisz, Kristof
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides a method for the treatment and prevention of urinary incontinence in mammals, e.g. human males and females especially nonpregnant , female mammals by administering a nitric oxide synthase substrate and/or nitric oxide donor, alone or in combination with an estrogenic agent and/or a progestational substance, with or without supplementation with an alphaadrenergic agonist, beta-adrenergic receptor blocking agent cholinergic-, receptor blocking compound or a cholinergic-receptor-stimulating drug as well , as pharmaceutical compositions useful in practicing the methods of this invention.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 21, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 21, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 21, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.